Cargando…

Can we consider procalcitonin as a consolidated biomarker in sepsis management?

Detalles Bibliográficos
Autores principales:	Garcia-de-Lorenzo, A., Sanchez, S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366909/ https://www.ncbi.nlm.nih.gov/pubmed/25810606 http://dx.doi.org/10.4103/0972-5229.152751

Ejemplares similares

Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011)

Overt hypothyroidism in pregnancy: Can we consider medical termination of pregnancy?
por: Kalra, Sanjay, et al.
Publicado: (2013)

Quality in computed tomography angiography: we start with what can be considered normal
por: Nacif, Marcelo Souto
Publicado: (2022)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016)

What procalcitonin brings to management of sepsis in the ICU
por: Wolff, Michel, et al.
Publicado: (2010)

Monitoring treatment response in abdominal sepsis with procalcitonin - if only!
por: Eckmann, Christian, et al.
Publicado: (2013)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Can We Consider PR Interval to Screen Patients for Cardiac Resynchronization Therapy?
por: Martinelli Filho, Martino
Publicado: (2018)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Procalcitonin and Other Biomarkers of Sepsis in Newborns in the Intensive Care Unit
por: Bartolovic, Daniela, et al.
Publicado: (2011)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Diagnostic utility of procalcitonin as a biomarker for late-onset neonatal sepsis
por: Liu, Chunmei, et al.
Publicado: (2020)

Umbilical Cord Procalcitonin to Detect Early-Onset Sepsis in Newborns: A Promising Biomarker
por: Dongen, O. R. E., et al.
Publicado: (2021)

Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011)

The golden era of videolaryngoscopy: costs we should consider
por: Choi, Geun Joo
Publicado: (2022)

An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis
por: Walker, Sarah, et al.
Publicado: (2022)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Should We Consider Screening Spirometry in Individuals Who Are “Asymptomatic”?
por: Fortis, Spyridon
Publicado: (2022)

Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient
por: Nargis, Waheeda, et al.
Publicado: (2014)

Biomarkers of Sepsis
por: Agnello, Luisa, et al.
Publicado: (2023)

Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008)

Procalcitonin – Assisted Antibiotic Strategy in Sepsis
por: Trásy, Domonkos, et al.
Publicado: (2017)

Clinics and Practice: Consolidating Best Practices in Periodontal Management
por: D’Ambrosio, Francesco
Publicado: (2023)

Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
por: Schuetz, Philipp, et al.
Publicado: (2017)

Efficiency diagnostic and advantages of procalcitonin and C-reactive protein in the early diagnosis of sepsis
por: De la Torre-Prados, M, et al.
Publicado: (2010)

Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3
por: Jekarl, Dong Wook, et al.
Publicado: (2019)

Consolidating Strengths
por: Bhattacharya, Sanjoy
Publicado: (2015)

Journalistic Consolidation
Publicado: (1878)

Evaluation of procalcitonin in patients with sepsis in Albanian adults
por: Puca, E, et al.
Publicado: (2012)

How Should We Consider New Theories of Chiari Malformation Pathogenesis?
por: Chou, Dean
Publicado: (2019)

DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin
por: Gao, Liqin, et al.
Publicado: (2017)

A limited set of molecular biomarkers may provide superior diagnostic outcomes to procalcitonin in sepsis
por: Brandon, RB, et al.
Publicado: (2012)

Procalcitonin: “To Follow or Not to Follow” That's the Question
por: Todi, Subhash K
Publicado: (2021)

Pain management following laparoscopy: Can we do better?
por: Tobias, Joseph D.
Publicado: (2013)

Obesity and weight management: What can we do as gastroenterologists?
por: Wang, Xia-Qing, et al.
Publicado: (2020)

How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?
por: Shankar-Hari, M.
Publicado: (2017)

Procalcitonin is an essential biomarker for hydrocortisone, ascorbic acid, and thiamine (HAT) therapy in patients with sepsis
por: Marik, Paul E.
Publicado: (2019)

Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients
por: Juneja, Deven, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbbhai50jh9a79os1l3lb60sq8